"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

What’s worse, an additional 3 million adults with diabetes in the U.S. never receive a diagnosis, let alone necessary care. 4 ...

“This is a win for people with diabetes, offering more people world-leading Libre technology,” said Jared Watkin, executive vice president of Abbott’s diabetes care business, in a statement.

Jared Watkin, senior vice president of Abbott’s diabetes care unit, agreed with Brewer’s assertions. He pointed out that Abbott’s FreeStyle Libre portfolio is the most widely used and ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Abbott Laboratories (NYSE: ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc. (NASDAQ: TNDM) announced a new agreement with Abbott to develop and ...

The company revolutionized diabetes care 10 years ago with its world-leading Libre continuous glucose monitoring portfolio, which today is used by 7 million people in more than 60 countries. 4 ...

Abbott diabetes care business chief medical officer Mahmood Kazemi said: "These data are transformative and show just how valuable FreeStyle Libre technology is for managing both diabetes and ...

Abbott Laboratories has petitioned the Internal Revenue Service in federal tax court for a $24.3 million tax refund and a redetermination of numerous IRS-claimed deficiencies in its federal income ...

The American Diabetes Association and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity and metabolic dysfunction.

Abbott’s 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care Provided by Accesswire Feb 5, 2025 1:30am ...